Biopharmaceutical Development

We recognize both the significant commercial value and the critical humanitarian value of your highly purified intermediates, which is why we offer an assortment of cGMP-ready automated fluid management system platforms tailored to large therapeutic proteins. Reliably enhance the viral safety of your product, improve the operating efficiency of the downstream manufacturing suite or install a high-yielding protein capture and polishing system.

What Is Biopharmaceutical Development?

Biopharmaceuticals represent a class of medicines that are among the most sophisticated achievements of modern science. Unlike traditional pharmaceuticals that are chemically synthesized and typically have a well-defined structure, biopharmaceuticals are large, complex molecules or mixtures of molecules made from living organisms. These biological products include a wide range of products such as vaccines, blood components, gene therapies, and cells used in cell therapy. The history of biopharmaceuticals dates to the 1980s with the advent of recombinant DNA technology, which allowed for the production of human insulin and growth hormone. Since then, the industry has expanded rapidly, with biopharmaceuticals offering high efficacy and fewer side effects compared to conventional drugs. Today, they are used to treat and prevent an array of diseases, including cancers, diabetes, and autoimmune disorders.

 

The potential of the biopharmaceutical market is vast and continues to grow at a remarkable pace. Innovations in biopharmaceuticals are not only evolving existing treatment archetypes but also bringing new concepts to the market, such as regenerative medicine and gene therapies. The operational and technological challenges of producing these complex molecules at an industrial scale are significant, requiring sophisticated manufacturing capabilities and expertise. Despite these challenges, the efficacy and ability of biopharmaceuticals to address previously untreatable conditions allow companies to command high prices for innovative drugs. With continuous research yielding new types of products and the FDA playing a critical role in their approval, the biopharmaceutical industry is poised to maintain its trajectory of rapid growth and innovation.

Related Products

3-Pump Inline Buffer Formulation System

Learn More

5-Pump Inline Buffer Formulation System

Learn More

ACS ERGO Column

Learn More

Bioprocess Chrom System

Learn More

DAC ERGO LC Column

Learn More

DAC Flash LC Column

Learn More

DAC HPLC Column

Learn More

DAC MPLC Column

Learn More

DAC UHPLC Column

Learn More

Flash LC System

Learn More

847 CONTINUUM PROGRAM

Enable production continuity with a comprehensive suite of aftermarket parts and services.

Newsletter Sign-Up